close
close

Pfizer Earnings Above, Third Quarter Revenues Down

Investing.com – Pfizer (NYSE:PFE) on Tuesday reported third-quarter earnings that topped analyst expectations and revenue that was below forecasts.

The company reported earnings per share of $0.78 on revenue of $13.3 billion. Analysts polled by Investing.com expected EPS of $0.75 on revenue of $13.55 billion. This compared to EPS of $0.67 on revenue of $12.90 billion in the same period a year earlier. In the previous quarter, the company observed EPS of $0.81 on revenue of $13.47 billion.

Pfizer shares are up 19.35% for the year, outperforming the S&P Global (NYSE:SPGI) 100 Index, which is down 3.51% year-to-date.

Pfizer is tracking the performance of other major healthcare sectors this month

On October 16, J&J (NYSE:JNJ) observed third-quarter EPS of $2.05 on revenue of $20.35 billion compared to forecast EPS of $2.03 on revenue of $20.05 billion.

Novartis ADR’s Oct. 18 earnings beat analyst expectations, with third-quarter EPS of $1.32 and revenue of $12.78 billion. Investing.com analysts expected EPS of $1.3 on revenue of $12.94 billion

Stay up to date with all upcoming earnings reports by visiting the earnings calendar on Investing.com

Related articles

Coca-Cola ranks first in sales estimates

Coca-Cola profits, revenues better in the third quarter

Fidelity National Info Profits soared, third quarter revenues were lower